Assessment of associations between neutrophil extracellular trap biomarkers in blood and thrombi in acute ischemic stroke patients Tristan BaumannNicole de BuhrRamona Schuppner OriginalPaper Open access 09 June 2024
ET1 acts as a potential plasma biomarker and therapeutic target in deep venous thrombosis rat model Zhanqi WangZhangmin WuZhong Chen OriginalPaper Open access 02 June 2024
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study Maria Cristina VedovatiLiqi ShuMaurizio Paciaroni OriginalPaper Open access 02 June 2024
Effect of Ultrasound on Thrombus debris during Sonothrombolysis in a Microfluidic device Xiaobing ZhengYunfan PanShuguang Zhang OriginalPaper 02 June 2024
Poly (ADP-ribose) Polymerase-1 modulations in the genesis of thrombosis Raishal SafdarAastha MishraMohammad Zahid Ashraf ReviewPaper 24 May 2024
NEUT-RI, a surrogate marker of NETosis is lower in patients with strong IgM antiphospholipid antibodies Sylvie BouvierMathieu FortierJean-Christophe Gris BriefCommunication 18 May 2024
Patent foramen ovale closure in ischemic stroke patients with and without thrombophilia: a systematic review and meta-analyses Xue Yang LimNicholas LX GaoBenjamin YQ Tan ReviewPaper 18 May 2024
Optimizing resource allocation: Cost-effectiveness of specified D-dimer cut-offs in cancer patients with suspected venous thromboembolism Teodora BiciuscaLeon D. GruenewaldVitali Koch OriginalPaper Open access 18 May 2024
Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial Pedro Gabriel Melo de Barros e SilvaRemo H. M. Furtadoon behalf of the ACTION Coalition COVID-19 Brazil IV Investigators OriginalPaper 18 May 2024
Factor XI as a new target for prevention of thromboembolism in cardiovascular disease: a meta-analysis of randomized controlled trials Ahmed E. AliMohamed K. AwadMuhammad S. Mazroua OriginalPaper 18 May 2024
Optimal hemodynamic parameters for risk stratification in acute pulmonary embolism patients Marco ZuinStanislav HenkinGregory Piazza OriginalPaper 18 May 2024
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2 Hiroshi MabuchiRyusuke NishikawaTakeshi Kimura OriginalPaper 18 May 2024
Cancer progression and tumor hypercoagulability: a platelet perspective Yifan ZhangJingtong ZengZuoqing Song ReviewPaper 17 May 2024
Comparison of rivaroxaban and low molecular weight heparin in the treatment of cancer-associated venous thromboembolism: a Swedish national population-based register study Marie LinderAnders EkbomDiego Hernan Giunta OriginalPaper Open access 12 May 2024
Differences in quality of anticoagulation care delivery according to ethnoracial group in the United States: A scoping review Sara R. VazquezNaomi Y. YatesMary M. McFarland OriginalPaper Open access 11 May 2024
Dual Antiplatelet Therapy vs Alteplase in Adult Patients with Acute Minor Ischemic Stroke: A Systematic Review and Meta-Analysis Patricia VianaJessica Hoffmann RelvasJamary Oliveira-Filho ReviewPaper 09 May 2024
Protein C and S activities in COVID-19: A systematic review and meta-analysis Zahra KhoshnegahPayam SiyadatHassan Mansouritorghabeh ReviewPaper 09 May 2024
Optimal intravenous antiplatelet therapy in patients with ST-elevation myocardial infarction: is the picture becoming clearer? Mohamed Farag Editorial 08 May 2024
Intraoperative haemoadsorption for antithrombotic drug removal during cardiac surgery: initial report of the international safe and timely antithrombotic removal (STAR) registry Michael SchmoeckelMatthias ThielmannRobert F. Storey OriginalPaper Open access 06 May 2024
Biochemical risk factors and outcomes of acute promyelocytic leukemia patients with thrombotic events: a matched pair analysis Xiaojing SongCheng ChiYu Wang OriginalPaper 03 May 2024
Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claims Gregory Y. H. LipVirginia NoxonSteven Deitelzweig OriginalPaper Open access 02 May 2024
Beyond silence: evolving ultrasound strategies in the battle against cardiovascular thrombotic challenges Zhiwen WangNan JiangBo Hu ReviewPaper 30 April 2024
Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma Irene Sánchez PrietoIsabel Gutiérrez JomarrónJulio García-Suárez OriginalPaper Open access 27 April 2024
Multimorbidity disease clusters are associated with venous thromboembolism: an extended cross-sectional national study Jonatan AhrénMirNabi PirouzifardBengt Zöller OriginalPaper Open access 27 April 2024
Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis Cho-Han ChiangOmer AhmedCho-Hung Chiang BriefCommunication 26 April 2024
Endovascular thrombectomy in wake-up stroke guided by arterial spin-labeling and fluid-attenuated inversion recovery versus diffusion-weighted imaging mismatch on MRI Hong-Feng WenQin LiJi-Chen Du OriginalPaper 25 April 2024
The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease Ahmed E. AliRichard C. Becker ReviewPaper Open access 25 April 2024
Layered plaque is associated with high levels of vascular inflammation and vulnerability in patients with stable angina pectoris Takayuki NiidaDaisuke KinoshitaIk-Kyung Jang OriginalPaper 22 April 2024
Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases Julie WangPrahlad HoHui Yin Lim ReviewPaper 22 April 2024
Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapy Margaret ShyuAngela LiuLeonard Naymagon OriginalPaper 21 April 2024
Comparison of the PADUA and IMPROVE scores in assessing venous thromboembolism risk in 42,257 medical inpatients in China Hou YifangDuan JunDeng Xiaomei OriginalPaper 21 April 2024
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide Marcin SadowskiMichał ZąbczykAnetta Undas OriginalPaper Open access 21 April 2024
Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies Beatriz Vieira NetoValéria TavaresRui Medeiros OriginalPaper 20 April 2024
Primary thromboprophylaxis in cancer outpatients – real-world evidence Joana Liz-PimentaValéria TavaresRui Medeiros OriginalPaper 20 April 2024
Factor XI: structure, function and therapeutic inhibition Ahmed E. AliRichard C. Becker ReviewPaper Open access 16 April 2024
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Angelo SilverioMichele BellinoGennaro Galasso OriginalPaper 13 April 2024
Evaluation of modified fixed dose four-factor prothrombin complex concentrate for warfarin reversal Meghan E. PetersonMegan P. JaynesColleen Morton OriginalPaper 06 April 2024
Management of DOAC-related bleeding in cancer patients: a single center-case series Sophia LeeJeremy A. RossCristhiam M. Rojas Hernandez OriginalPaper 31 March 2024 Pages: 677 - 682
One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke Yasutaka MurakamiKenichi TodoHideki Mochizuki OriginalPaper Open access 31 March 2024 Pages: 622 - 629
Impact of rise and fall phases of shear on platelet activation and aggregation using microfluidics Xuemei GaoTiancong ZhangYuan Li OriginalPaper 31 March 2024 Pages: 576 - 586
Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome Yee-Jen WuChien-Chih WuChi-Chuan Wang OriginalPaper 31 March 2024 Pages: 537 - 546
Thromboembolic events after major bleeding events in patients with mechanical heart valves: a 13-year analysis Pascal AugustinStefan AndreiPhilippe Montravers OriginalPaper 31 March 2024
Management of direct oral anticoagulant drug interactions in hospitalized patients Mohsen H. Al ZariaLeo F. BuckleyJohn Fanikos OriginalPaper 30 March 2024 Pages: 598 - 602
COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment Li-Hua LiuYang-Zhao ZhouSheng-Lan Tan OriginalPaper 25 March 2024 Pages: 730 - 738
Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity Erica OkazakiBárbara Gomes BarionFernanda Andrade Orsi OriginalPaper 25 March 2024 Pages: 721 - 729
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database Bang TruongLori HornsbyJingjing Qian OriginalPaper Open access 20 March 2024 Pages: 638 - 649
Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry Omri CohenGili Kenetand the RIETE investigators OriginalPaper 16 March 2024 Pages: 710 - 720
Superficial vein thrombosis and its relationship with malignancies: a prospective observational study Alejandro Díez-VidalJavier Gómez LópezYale Tung-Chen OriginalPaper 16 March 2024 Pages: 650 - 657
Antithrombotic strategies for preventing graft failure in coronary artery bypass graft Maria Sara MauroSimone FinocchiaroDavide Capodanno ReviewPaper Open access 16 March 2024 Pages: 547 - 557
Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model Mario AramberriJesús González-OlmedoCarmen Diaz-Pedroche OriginalPaper 14 March 2024 Pages: 668 - 676